The Scripps Research Institute Scientists Design a Potential Drug Compound that Attacks Parkinson’s Disease on Two Fronts

Published: Jun 21, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found a compound that could counter Parkinson’s disease in two ways at once. In a new study published recently online ahead of print by the journal ACS Chemical Biology, the scientists describe a “dual inhibitor”—two compounds in a single molecule—that attacks a pair of proteins closely associated with development of Parkinson’s disease.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news